test altFunding OpportunitiesAward ManagementComliance Review and OversightEducation and TrainingTechnology Transfer
Office of Research and Technology Management
Promoting Research, Advancing Scholarship, Fostering Innovation
Identify Funding Oportunities Proposal Development Award Management
Compliance Review and Oversight Education and Training Technology Transfer


Welcome from the Vice President for Research

CWRU researchers are among the most distinguished in the world. We have 16 Nobel Laureates among current and former faculty and alumni, 4 members of the National Academies of Sciences, 7 members of the National Academy of Engineering, and 8 members of the Institute of Medicine. We also partner with artistic and cultural institutions on a broad range of projects that make important scholarly contributions in the humanities and social sciences.

Extraordinary research requires an outstanding infrastructure. Our Office of Research & Technology Management provides support to seek out grant funding, to facilitate industrial sponsorship, and to transfer university technologies to the marketplace. This is a place for people driven to make a difference, and our office exists to help them succeed.

Contact us. We want you to see what our campus can offer.

Dr. Suzanne Rivera


Research Matters

Research Matters

Use the following link in order to view previous editions of Research Matters and Research News and Updates Research Matters Archive .




Latest News

Research Newsletter
May 14, 2015  

Ferring Pharmaceuticals

Ferring Pharmaceuticals is pleased to announce that the Ferring Innovation Grants Portal is now open and accepting applications. The goal of the Ferring Innovation Grants program is to fund projects designed to identify novel drug targets that are:

  • For indications within their core therapeutic areas (Reproductive Health, Urology, Gastroenterology)

  • Addressable with peptides and/or proteins

  • Exploratory, discovery and/or preclinical in nature


The program will provide a limited number of grants in the amount of $50,000. The grants DO NOT carry indirect costs and are not renewable. Funding will not be provided for clinical studies, studies which require collection of patient biopsies or studies to develop small molecules. In all cases the intellectual property rights remain with the applicant.

Application Deadline: July 1st, 2015

For more information visit the Ferring Pharmaceuticals webpage.

 
Congratulations to the Research ShowCASE and Intersections Presentation Winners

Postdoctoral First Place Winners:
Intekhab Alam
Melissa Babcook
Andrew Cooper
Marie Gadziola
Ranganath Mamidi

Postdoctoral Honorable Mention:
David Soler

Graduate Student First Place Winners:
Eric Abenojar
Nasmah Bastaki
Jared Bendis
Shoshana Ginsburg
John Krebs
Ronald Leibach
Breanna Perlmutter

Graduate Student Honorable Mention:
Mark Asirwatham
Jang Ik Cho
Jennifer Espartero
Michael Gearhart
Priyanka Gokhale
Rachel Matthews
Seyed Mohsen Seifi

Undergraduate First Place Winners:
Taylor Nguyen (Mentor - Mohan Sankaran)
Elishama Kanu (Mentor - Hillel Chiel)
Anisha Garg (Mentor - Barbara Kuemerle)
Raghav Tripathi (Mentor - Jeremy Bordeaux)
Diana Acosta (Mentor - Roger French)
Margaret Mack (Mentor - Zheng-Rong Lu)
Moriah Watts (Mentor - Marilyn Lotas)
William Qu (Mentor - Paul Tesar)
Logan Smith (Mentor - Julia Dobosotskaya)
Harini Ushasri and Liana Manuel (Mentor - John Paul Stephens)
Alayna Klco (Mentor - Katia Almeida)

Undergraduate Second Place Winners:
Paul Advincula (Mentor - Rigoberto Advincula)
Samantha Butler (Mentor - Chung-Chiun Liu)
Sara Mithani (Mentor - Leena Palomo)
Rachael Wieber and Breanon Glover (Mentor - Mary Quinn Griffin)
Arvind Haran (Mentor - Michael Jenkins)
Elishama Kanu (Mentor - Hillel Chiel)
Katie Pezzot (Mentor - Jiayang Sun)
Samir Shah (Mentors: Matthew Williams and Robert Kirsch)
Kathy Lin (Mentor - Amy Przeworski)
Lauren Pohl (Mentor - Amy Przeworski)
Lisa Richey (Mentor - Kathryn Rothenberg)

 
Reminder: New NIH biosketch format effective May 25th, 2015

The new NIH Biosketch format will take effect for applications submitted on or after May 25, 2015. Key changes include:

  • Extending the biosketch page limit to 5 pages
  • Allowing PIs and researchers to include up to four references in their personal statement
  • Allowing researchers to describe up to five of their most important contributions to science
  • Allowing researchers to include a link that provides access to a full list of your published work

Kathy Blazar, interim director at our Cleveland Health Sciences Library, has prepared a power point presentation that can help you navigate the new format: http://www.case.edu/chsl/library/NIHBiosketch.pptx.

Additional points to consider:
  • Investigators need to update their personal profile on eRA Commons
  • Public access compliance need to be up to date
  • All non-CWRU, most especially international, collaborators must also be compliant if they are named as key personnel.
If you have questions about the process, please contact Kathy Blazar at kcb2@case.edu.

 
Take Advantage of All Pivot Has to Offer

For years, Community of Science (COS) has been recognized around the world for its funding from a wide variety of sources as well as its access to the world’s research community.

CWRU has subscribed to COS's new product, Pivot, which provides you the edge by bringing together the right research opportunities, funding, and people—quickly and easily. It provides global and local connections that strengthen research by exploring new avenues for funding and collaboration—for faculty, staff researchers, and graduate students.

Pivot can:

  • provide access to the most comprehensive global source of funding opportunities;
  • identify research expertise from within or outside of CWRU;
  • foster collaboration by cultivating essential partnerships and alliances; and
  • build strong network connections for future opportunities.
Learn more about how to use all the features Pivot has to offer.

Sign up for a Pivot Webinar: https://refworks.webex.com/refworks/onstage/g.php?p=4&t=m.

 
Department of Health and Human Services – Food & Drug Administration

The goal of this program is to support the advancement of regulatory science that can facilitate the implementation and the assessment of emerging manufacturing technology in the pharmaceutical sector. Emerging manufacturing technology can be viewed as a technology that has the potential to modernize the pharmaceutical manufacturing body of knowledge to support more robust, predictable, and/or cost-effective processes and with which the FDA has limited review or inspection experiences, due to its relative novelty. Examples of such elements include innovative or novel (1) product manufacturing technology, such as the dosage form; (2) manufacturing process (e.g., design, scale-up, and/or commercial scale); and/or (3) testing technology.

Application Deadline: June 30 , 2015

For more information visit the Grants.Gov webpage.

 

If you have news or information that you wish to have included in this update, please send it via e-mail to Tracy Wilson-Holden at tracy.wilson-holden@case.edu no later than 5 pm on the Monday of the week that the update is to be distributed. If you know of individuals who may be interested in receiving this update, please forward this e-mail to them. To subscribe or unsubscribe to Case Research News, email your request to Tora Williams at tora.williams@case.edu.

Please note: At the time of this transmission, all links functioned. However, Case Research News cannot guarantee that the information will not move or be deleted.